You Searched For: Carbon


92 405  results were found

Sort Results

List View Easy View (new)
SearchResultCount:"92405"
Description: 2-(Diphenylphosphino)biphenyl 97%
Catalog Number: BLDPBD165228-25G
UOM: 1 * 25 g
Supplier: BLD PHARMATECH GMBH


Description: The protein encoded by this gene can hydrolyze substrates such as AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif, which is part of the loop that binds to the substrate. This gene has been found to be a tumor suppressing gene. Several transcript variants, but only one of them protein-coding, have been found for this gene. [provided by RefSeq, Dec 2012].
Catalog Number: BOSSBS-10228R-FITC
UOM: 1 * 100 µl
Supplier: Bioss


Description: The protein encoded by this gene can hydrolyze substrates such as AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif, which is part of the loop that binds to the substrate. This gene has been found to be a tumor suppressing gene. Several transcript variants, but only one of them protein-coding, have been found for this gene. [provided by RefSeq, Dec 2012].
Catalog Number: BOSSBS-10228R-CY3
UOM: 1 * 100 µl
Supplier: Bioss


Description: Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyzes the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.Tissue specificity:Liver and kidney.Involvement in disease:Defects in DPYS are the cause of dihydropyrimidinase deficiency (DHPD). DHPD is an autosomal recessive disorder characterized by dihydropyrimidinuria and associated with a variable clinical phenotype: epileptic or convulsive attacks, dysmorphic features and severe developmental delay, and congenital microvillous atrophy.
Catalog Number: BOSSBS-8287R-FITC
UOM: 1 * 100 µl
Supplier: Bioss


Description: Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyzes the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.Tissue specificity:Liver and kidney.Involvement in disease:Defects in DPYS are the cause of dihydropyrimidinase deficiency (DHPD). DHPD is an autosomal recessive disorder characterized by dihydropyrimidinuria and associated with a variable clinical phenotype: epileptic or convulsive attacks, dysmorphic features and severe developmental delay, and congenital microvillous atrophy.
Catalog Number: BOSSBS-8287R-HRP
UOM: 1 * 100 µl
Supplier: Bioss


Description: Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyzes the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.Tissue specificity:Liver and kidney.Involvement in disease:Defects in DPYS are the cause of dihydropyrimidinase deficiency (DHPD). DHPD is an autosomal recessive disorder characterised by dihydropyrimidinuria and associated with a variable clinical phenotype: epileptic or convulsive attacks, dysmorphic features and severe developmental delay, and congenital microvillous atrophy.
Catalog Number: BOSSBS-8287R-A750
UOM: 1 * 100 µl
Supplier: Bioss


Description: The protein encoded by this gene can hydrolyze substrates such as AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif, which is part of the loop that binds to the substrate. This gene has been found to be a tumor suppressing gene. Several transcript variants, but only one of them protein-coding, have been found for this gene. [provided by RefSeq, Dec 2012].
Catalog Number: BOSSBS-10228R-CY7
UOM: 1 * 100 µl
Supplier: Bioss


Description: The protein encoded by this gene can hydrolyze substrates such as AMP-morpholidate, AMP-N-alanine methyl ester, AMP-alpha-acetyl lysine methyl ester, and AMP-NH2. The encoded protein interacts with these substrates via a histidine triad motif, which is part of the loop that binds to the substrate. This gene has been found to be a tumor suppressing gene. Several transcript variants, but only one of them protein-coding, have been found for this gene. [provided by RefSeq, Dec 2012].
Catalog Number: BOSSBS-10228R-A488
UOM: 1 * 100 µl
Supplier: Bioss


Description: 1,5-Diphenylcarbazone 95%, Technical Grade
Catalog Number: APOSOR52237-5G
UOM: 1 * 5 g
Supplier: APOLLO SCIENTIFIC


Description: 1,5-Diphenylcarbazone suitable for colorimetric analysis
Catalog Number: ACRO154450500
UOM: 1 * 50 g
Supplier: Thermo Scientific


Description: 3-(3,4-Dihydroxyphenyl)-L-alanine
Catalog Number: MOLEM21789468
UOM: 1 * 25 g
Supplier: Molekula


Description: 3-(3,4-Dihydroxyphenyl)-L-alanine
Catalog Number: PROOICRS0334
UOM: 1 * 100 mg
Supplier: LGC Standards PROMOCHEM


Description: Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyzes the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.Tissue specificity:Liver and kidney.Involvement in disease:Defects in DPYS are the cause of dihydropyrimidinase deficiency (DHPD). DHPD is an autosomal recessive disorder characterised by dihydropyrimidinuria and associated with a variable clinical phenotype: epileptic or convulsive attacks, dysmorphic features and severe developmental delay, and congenital microvillous atrophy.
Catalog Number: BOSSBS-8287R-A680
UOM: 1 * 100 µl
Supplier: Bioss


Description: (S,S)-(-)-Hydrobenzoin ≥98%
Catalog Number: L14082.14
UOM: 1 * 25 g
Supplier: Alfa Aesar

Description: Catalyzes the second step of the reductive pyrimidine degradation, the reversible hydrolytic ring opening of dihydropyrimidines. Can catalyzes the ring opening of 5,6-dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to N-carbamyl-amino isobutyrate.Tissue specificity:Liver and kidney.Involvement in disease:Defects in DPYS are the cause of dihydropyrimidinase deficiency (DHPD). DHPD is an autosomal recessive disorder characterized by dihydropyrimidinuria and associated with a variable clinical phenotype: epileptic or convulsive attacks, dysmorphic features and severe developmental delay, and congenital microvillous atrophy.
Catalog Number: BOSSBS-8287R-A488
UOM: 1 * 100 µl
Supplier: Bioss


Description: 1,2-Bis(diphenylphosphino)ethane
Catalog Number: APOSOR315704-25G
UOM: 1 * 25 g
Supplier: APOLLO SCIENTIFIC


1 057 - 1 072 of 92 405